CEO Apollo Health System
Oncology
Dr. David P. Ellent, MD
|
|
Give Review
Doctor David P. Ellent, MD works in the field of Oncology. He attended Rutgers New Jersey Medical School. Rutgers New Jersey Medical School is ranked 76/0 in Research/PrimaryCare. David Ellent is also a published MD. He has 1 paper published. The most recent paper is: Cyclooxygenase-2-derived prostaglandin e2 protects mouse embryonic stem cells from apoptosis. He accepts Medicare.
Publications
Schools
University of Medicine And Dentistry of New Jersey Newark
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Anemia
- Bladder Cancer
- View All
Doctors Specialties
- Oncology
Accepted Insurances
Education
-
University of Texas MD Anderson Cancer Center -
UMDNJ-New Jersey Medical School -
Rutgers New Jersey Medical School
Hospital
-
Houston Northwest Medical Center
Drug Facts
| NPI NUMBER | 1427081710 | |
| NPPES Provider LastName | ELLENT | |
| NPPES Provider FirstName | DAVID | |
| NPPES Provider ZIPCode | 773803256 | |
| NPPES Provider State | TX | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 1121.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 100.0 | |
| Percent Opioid Claims | 8.92 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1427081710 |
| Last Name Of The Provider | ELLENT |
| First Name Of The Provider | DAVID |
| View All |
Similar Doctors
|
Dr. Mary K. Crow, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Kumud S. Tripathy, MD
This Doctor is OpenDoctor Recommended.
|